-
公开(公告)号：US09120775B2
公开(公告)日：2015-09-01
申请号：US13861331
申请日：2013-04-11
IPC分类号： C07D405/14 , C07D231/56 , A61K31/416 , C07D401/04 , A61K31/4439 , C07D405/12 , A61K45/06 , C07D403/12 , A61K31/427 , A61K31/706 , A61K38/05 , A61K38/08 , C07D401/14 , C07D417/04 , A61K38/06
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
摘要翻译： 本发明涉及式（I）的病毒聚合酶抑制剂或其盐，N-氧化物，溶剂合物，水合物，外消旋物，对映体或异构体，其制备方法及其在治疗黄病毒病毒感染如丙型肝炎病毒 （HCV）感染。
-
公开(公告)号：US20150065445A1
公开(公告)日：2015-03-05
申请号：US14391500
申请日：2013-04-11
IPC分类号： C07D405/12 , C07D403/12 , C07D231/56 , A61K31/416 , C07D401/04 , A61K45/06 , A61K31/4439
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
摘要翻译： 本发明涉及式（I）的病毒聚合酶抑制剂或其盐，N-氧化物，溶剂合物，水合物，外消旋物，对映体或异构体，其制备方法及其用于治疗黄病毒病毒感染如丙型肝炎病毒 （HCV）感染。
-
公开(公告)号：US20130274218A1
公开(公告)日：2013-10-17
申请号：US13861331
申请日：2013-04-11
IPC分类号： C07D405/14 , A61K31/416 , A61K45/06 , A61K31/4439 , C07D405/12 , C07D403/12 , C07D231/56 , C07D401/04
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
摘要翻译： 本发明涉及式（I）的病毒聚合酶抑制剂或其盐，N-氧化物，溶剂合物，水合物，外消旋物，对映体或异构体，其制备方法及其用于治疗黄病毒病毒感染如丙型肝炎病毒 （HCV）感染。
-
公开(公告)号：US08785478B2
公开(公告)日：2014-07-22
申请号：US13861325
申请日：2013-04-11
IPC分类号： A61K31/4427 , A61K31/427 , A61K31/416 , C07D401/02 , C07D417/02 , C07D231/56 , C07D417/04 , C07D403/12 , C07D401/14 , C07D401/04 , A61K38/08 , C07D405/14 , C07D405/12 , A61K31/706 , A61K31/4439 , A61K38/05 , A61K45/06
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
摘要翻译： 本发明涉及式（I）的病毒聚合酶抑制剂或其盐，N-氧化物，溶剂合物，水合物，外消旋物，对映体或异构体，其制备方法及其用于治疗黄病毒病毒感染如丙型肝炎病毒 （HCV）感染。
-
公开(公告)号：US09447080B2
公开(公告)日：2016-09-20
申请号：US14391500
申请日：2013-04-11
IPC分类号： A01N43/00 , A61K31/00 , C07D405/12 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/08 , A61K45/06 , C07D401/04 , C07D401/14 , C07D405/14 , C07D417/04 , A61K31/416 , C07D231/56 , C07D403/12 , A61K38/06
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
-
公开(公告)号：US09365554B2
公开(公告)日：2016-06-14
申请号：US14391506
申请日：2013-04-11
IPC分类号： C07D231/56 , C07D403/12 , C07D405/12 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/08 , A61K45/06 , C07D401/04 , C07D401/14 , C07D405/14 , C07D417/04 , A61K31/416 , A61K38/06
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
-
公开(公告)号：US20150175592A1
公开(公告)日：2015-06-25
申请号：US14391506
申请日：2013-04-11
IPC分类号： C07D417/04 , A61K31/4439 , A61K45/06 , A61K31/427 , C07D401/14 , C07D401/04 , C07D405/14
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
-
公开(公告)号：US20130274179A1
公开(公告)日：2013-10-17
申请号：US13861325
申请日：2013-04-11
IPC分类号： C07D417/04 , A61K31/4439 , C07D405/14 , A61K45/06 , C07D401/14 , A61K31/706 , A61K38/08 , A61K38/05 , C07D401/04 , A61K31/427
CPC分类号： C07D405/12 , A61K31/416 , A61K31/427 , A61K31/4439 , A61K31/706 , A61K38/05 , A61K38/06 , A61K38/08 , A61K45/06 , C07D231/56 , C07D401/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D417/04 , A61K2300/00
摘要： The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.021 秒)
